|
November 2009 FAQs
Does acetaminophen reduce the immunologic response to vaccines in children?
What medications currently have restricted access programs?
What are the current treatment recommendations for Hepatitis B?
What place in therapy does oseltamivir 150 mg twice daily have for treatment of H1N1
October 2009 FAQs
What are the recommendations for the management of depression during pregnancy?
Who are the recommended target groups for receiving the novel influenza A (H1N1) 2009 monovalent vaccine according to the Centers for Disease Control and Prevention?
What is the recent data regarding the interaction between proton pump inhibitors and the thienopyridines (clopidogrel and prasugrel)?
Are the thiazolidinediones associated with an increased risk of acute cardiovascular events in patients with type 2 diabetes?
September 2009 FAQs
Mortality with schizophrenia—effects of antipsychotic treatment
Is famotidine effective for preventing ulcers in patients receiving low-dose aspirin?
Medication errors related to parenteral nutrition: data from a teaching hospital
What is Saxagliptin’s Place in Therapy?
August 2009 FAQs
What are the clinical data surrounding irrigation methods for the prevention of wound infections?
Do chlorhexidine baths prevent healthcare-associated infections?
What are the findings of the BARI 2D Study?
What are the new regulations for acetaminophen mandated by the Food and Drug Administration (FDA)?
July 2009 FAQs
Should beta-blockers be titrated to a target dose or a target heart rate in patients with heart failure?
Corticosteroids in severe sepsis and septic shock—results of a recent meta-analysis?
What is the role of tolvaptan for management of hyponatremia?
Antimicrobial Surgical Prophylaxis Guidelines Updated
June 2009 FAQs
Updated guidelines for the nutrition support in the adult critically ill patient: SCCM and ASPEN
Is clopidogrel plus aspirin an effective treatment in patients with atrial fibrillation?
Expert Consensus Document on Pulmonary Hypertension Released
What are the available clinical data and continuing concerns regarding rivaroxaban (Xarelto®)?
May 2009 FAQs
What are the recommendations found in the 2009 focused update to the American College of Cardiology Foundation/American Heart Association heart failure guidelines?
What is the recommended dose of low molecular weight heparin for thromboembolic prophylaxis in bariatric surgery?
Transdermal patches during MRI procedures: risk of serious burns
Glucose levels in the critically ill: how low should we go? Results of the NICE-SUGAR Study
April 2009 FAQs
What pharmacological therapy should be selected for patients with suspected oseltamivir-resistant influenza A (H1N1)?
When should aspirin be used for the primary prevention of cardiovascular disease?
Parenteral drug administration errors in intensive care units: a study
What is the role of vitamin K in nonbleeding patients with a supratherapeutic INR?
March 2009 FAQs
What is the role of parenteral thiazide diuretics?
What is the role of dexmedetomidine in sedation of critically ill patients?
Is it recommended to use nesiritide in the outpatient setting?
Overview of efficacy and safety of available topical thrombin products
February 2009 FAQs
Does fospropofol offer advantages over conventional propofol?
Do atypical antipsychotics increase the risk of sudden cardiac death similar to typical antipsychotics?
Intensive glycemic control and cardiovascular events: an update
The ACCOMPLISH study
January 2009 FAQs
Antiplatelet therapy and GI risk
Is continuous glucose monitoring associated with improved glycemic control in patients with type 1 diabetes?
What is the optimal CD4 count at which to start antiretroviral therapy?
December 2008 FAQs
Are perioperative beta blockers effective in preventing cardiovascular complications in non-cardiac surgery?
Can the “window” for alteplase administration in ischemic stroke be extended to 4.5 hours?
The JUPITER trial
Do any drugs for the treatment of diabetes reduce the risk of cardiovascular disease?
November 2008 FAQs
Should patients with coronary heart disease be screened and treated for depression?
What are alternatives to topical papain for wound care?
Can the intravenous formulation of vitamin K be administered orally?
What drugs should be avoided in myasthenia gravis?
October 2008 FAQs
Is the use of the combination of ezetimibe/simvastatin associated with causing cancer?
Is the combination of simvastatin and ezetimibe effective for patients with aortic stenosis?
Are all levothyroxine products created equal?
What is the role of romiplostim for the treatment of ITP?
September 2008 FAQs
Why is fondaparinux contraindicated in low body weight surgery patients but not in other low weight patients?
Which patients should be given antibiotics to prevent infective endocarditis?
Summary of the ACC/AHA 2008 guidelines
What is the role of recombinant activated Factor VII in intracranial hemorrhage?
The influence of nonadherence to antiepileptic drugs (AEDs) on mortality in epilepsy
August 2008 FAQs
Is bivalirudin an option for treating heparin-induced thrombocytopenia in patients not undergoing a percutaneous coronary intervention?
How can the potential for abacavir hypersensitivity reactions be minimized?
July 2008 FAQs
Diabetes control and macrovascular complications
Antipsychotics and risk in patients with dementia
Preoperative statins and effects on mortality
Low-molecular weight heparin for the treatment of thromboembolism in obese patients
June 2008 FAQs
Clinical controversy: The MENDS trial (maximizing efficacy of targeted sedation and reducing neurological dysfunction)
Cardiovascular Disease and Homocysteine
Pharmacist's role in the management of heart failure patients
May 2008 FAQs
Medication errors in US children’s hospitals
Is there a drug-drug interaction between clopidogrel and omeprazole?
Prasugrel: a thienopyridine drug on the horizon
Resistant hypertension: summary of the American Heart Association’s scientific statement
April 2008 FAQs
Intensive glycemic control may be detrimental for patients with type 2 diabetes: results of the ACCORD trial
A review of the update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack
ENHANCE trial: is there a role for ezetimibe in managing dyslipidemia?
What is the role of vasopressin in septic shock?
March 2008 FAQs
What anticoagulants can be given to a patient with heparin-induced thrombocytopenia during dialysis sessions?
Occupational exposure to hazardous drugs—recommendations for oral dosage forms
Warnings regarding sedative-hypnotic medications: an update
Tuberculosis in human immunodeficiency virus (HIV) patients: managing drug interactions
February 2008 FAQs
What are the new changes in USP 797 for 2008?
Are antipsychotics an appropriate treatment for aggressive challenging behavior in patients with an intellectual disability?
Haloperidol and cardiovascular concerns Recent News
The use of intralipid emulsion for the reversal of local anesthetic toxicity
January 2008 FAQs
New asthma guidelines
Hearing loss and PDE5 inhibitors
Haemophilus type b (Hib) vaccine shortage
Potential interaction between warfarin and cranberry juice: updated data
FAQs 2007
FAQs
2006
FAQs 2003
| 
